Vice Provost and Dean of Research
Showing 81-100 of 1,755 Results
-
Annelise E. Barron
Associate Professor of Bioengineering
On Partial Leave from 01/01/2026 To 06/30/2026Current Research and Scholarly InterestsBiophysical mechanisms of host defense peptides (a.k.a. antimicrobial peptides) and their peptoid mimics; also, molecular and cellular biophysics of human innate immune responses.
-
Michele Barry, MD, FACP
Drs. Ben & A. Jess Shenson Professor, Senior Associate Dean, Global Health, Director, Center for Innovation in Global Health, Professor of Medicine, Senior Fellow at the Woods Institute and Professor, by courtesy, of Health Policy
Current Research and Scholarly InterestsAreas of research
Ethical Aspects of research conducted overseas
Clinical Tropical Diseases
Globalization's Impact upon Health Disparities
Human and Planetary Heath
Women Leadership -
Greg Barsh
Professor of Genetics and of Pediatrics, Emeritus
Current Research and Scholarly InterestsGenetics of color variation
-
Michael Bassik
Associate Professor of Genetics
Current Research and Scholarly InterestsWe are an interdisciplinary lab focused on two major areas:(1) we seek to understand mechanisms of cancer growth and drug resistance in order to find new therapeutic targets(2) we study mechanisms by which macrophages and other cells take up diverse materials by endocytosis and phagocytosis; these substrates range from bacteria, viruses, and cancer cells to drugs and protein toxins. To accomplish these goals, we develop and use new technologies for high-throughput functional genomics.
-
Glaivy Batsuli, MD
Associate Professor of Pediatrics (Hematology/Oncology)
Current Research and Scholarly InterestsHemophilia is a rare inherited X-linked bleeding disorder characterized by the deficiency of blood clotting proteins factor VIII or factor IX. These individuals are at risk for spontaneous bleeds and trauma or surgery-induced bleeding. There have been remarkable advancements in the management of hemophilia to prevent these bleeding episodes and improve quality of life. However, the presence of neutralizing antibodies, called inhibitors, still dictates access to novel therapies such as factor replacement for bleed management and now FDA-approved gene therapies. The Batsuli Lab is focused on elucidating mechanisms of the immune response to blood coagulation proteins in bleeding disorders in order to develop strategies and therapeutics for inhibitor prevention and tolerance induction.
Dr. Batsuli's clinical research interests also include clinical trial participation for novel therapeutics & interventions in bleeding disorders such as hemophilia and von Willebrand disease in addition to coagulation issues & outcomes in ultra-rare bleeding disorders and sickle cell disease. -
Fiona Baumer
Assistant Professor of Neurology (Pediatric Neurology)
Current Research and Scholarly InterestsCauses of Disturbed Cognition in Pediatric Epilepsy
-
Mohsen Bayati
Carl and Marilynn Thoma Professor in the Graduate School of Business and Professor, by courtesy, of Electrical Engineering and of Radiation Oncology (Radiation Therapy)
Current Research and Scholarly Interests1) Healthcare management: I am interested in improving healthcare delivery using data-driven modeling and decision-making.
2) Network models and message-passing algorithms: I work on graphical modeling ideas motivated from statistical physics and their applications in statistical inference.
3) Personalized decision-making: I work on machine learning and statistical challenges of personalized decision-making. The problems that I have worked on are primarily motivated by healthcare applications. -
Tina Baykaner
Assistant Professor of Medicine (Cardiovascular Medicine)
BioTina Baykaner, MD, MPH is an Assistant Professor of Medicine in the Division of Cardiovascular Medicine and Cardiac Electrophysiology at Stanford University School of Medicine. She completed residency and fellowships in cardiovascular medicine and advanced heart failure at the University of California, San Diego, followed by fellowship training in cardiac electrophysiology at Stanford. She joined the Stanford faculty in 2018 and was promoted to Assistant Professor in 2023.
Dr. Baykaner’s research program focuses on atrial fibrillation (AF), cardio-oncology, and the integration of artificial intelligence and machine learning into cardiac electrophysiology. She is Principal Investigator of an NIH R01 investigating atrial fibrillation in patients with hematologic malignancies treated with tyrosine kinase inhibitors and previously led an NIH K23 award focused on personalizing AF management using machine learning. She also serves as co-investigator or consultant on multiple NIH-funded R01 projects in artificial intelligence, ventricular arrhythmias, and digital cardiovascular phenotyping. Her work spans AF mechanisms, ablation outcomes, digital health implementation, and equity in arrhythmia care.
She has authored over 200 peer-reviewed publications, book chapters, and abstracts, including more than 100 original research manuscripts, and has delivered over 100 invited lectures nationally and internationally. She served as a task force member for the 2024 EHRA/HRS/APHRS/LAHRS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation and holds editorial leadership roles, including Associate Editor for the Journal of Interventional Cardiac Electrophysiology and editorial board positions with multiple electrophysiology journals.
Dr. Baykaner is Vice-Chair of the Heart Rhythm Society Digital Education Committee and serves on national program and grant review committees, including NIH/NHLBI study sections. She is actively engaged in mentorship across undergraduate, medical, graduate, and postdoctoral levels, with mentees who have received national awards and progressed to electrophysiology fellowship and faculty positions.
Her clinical practice focuses on catheter ablation of atrial and ventricular arrhythmias, supraventricular tachycardias, management of inappropriate sinus tachycardia, cardiac implantable electronic device implantation and extraction, and advanced rhythm management strategies in complex patient populations. -
Philip Beachy
The Ernest and Amelia Gallo Professor, Professor of Urology, of Developmental Biology and, by courtesy, of Chemical and Systems Biology
Current Research and Scholarly InterestsFunction of Hedgehog proteins and other extracellular signals in morphogenesis (pattern formation), in injury repair and regeneration (pattern maintenance). We study how the distribution of such signals is regulated in tissues, how cells perceive and respond to distinct concentrations of signals, and how such signaling pathways arose in evolution. We also study the normal roles of such signals in stem-cell physiology and their abnormal roles in the formation and expansion of cancer stem cells.
-
Christopher Beaulieu M.D., Ph.D.
Professor of Radiology (Musculoskeletal Imaging)
On Leave from 06/01/2026 To 06/26/2026Current Research and Scholarly InterestsInformatics and image processing techniques that provide infrastructure for diagnosis in musculoskeletal imaging. Decision support for improving accuracy of bone tumor diagnosis. Improved methods for MRI in the musculoskeletal system.
-
Barry Behr, Ph.D., H.C.L.D.
Professor of Obstetrics and Gynecology (Reproductive Endocrinology and Infertility), Emeritus
Current Research and Scholarly InterestsDevelopment of improved embryo culture conditions in vitro. Blastocyst cultures. Embryo metabolism in vitro. Embryo maternal dialogue. Clinical application and integration of extended embryo culture systems. Monozygotic twinning. Prevention of multiple pregnancy. Sperm motility enhancers. Fluorescent and non-fluorescent markers of sperm morphology and viablility. Oocyte cryopreservation. Fertility preservation. Improving IVF outcome.
-
Corinne Beinat
Assistant Professor of Radiology (Molecular Imaging Program at Stanford)
Current Research and Scholarly InterestsThe focus of my research is to develop novel imaging and treatment strategies to detect and better manage cancer. This approach relies first on the identification and validation of molecular targets and biomarkers that are linked with underlying the underlying biology driving the initiation and progression of cancers. We then develop novel small molecule based radiotracers to monitor fundamental molecular and cellular processes occurring in living subjects using positron emission tomography (PET) with the goal of improving cancer diagnosis and management. We additionally develop novel peptide based theragnostic agents for stratification of patients with high receptor expression, treatment with targeted radionuclide therapy, and subsequent monitoring of treatment response. Our overall goal is to develop multiple clinically translatable strategies to improve cancer diagnosis, management, and outcomes.
